XTL Biopharmaceuticals Ltd. DPO Ratio 2011-2026 | XTLB

Annual DPO Ratio XTL Biopharmaceuticals Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	224	572	-

All numbers in USD currency

Maximum	Minimum	Average
572	224	398

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	186	$ 2.63	-1.22 %	$ 16.5 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Alnylam Pharmaceuticals ALNY	55	$ 316.2	-4.28 %	$ 41.4 B	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Завод ДИОД DIOD	30.3	-	-	-	Russia
Фармсинтез LIFE	306	-	-	-	Russia
Aptorum Group Limited APM	405	$ 0.89	-	$ 4.85 M	China
Teligent, Inc. TLGT	59.2	-	-13.85 %	$ 16.1 M	USA
Cerus Corporation CERS	242	$ 1.8	-2.7 %	$ 343 M	USA
AbbVie ABBV	65.5	$ 202.28	-2.11 %	$ 358 B	USA
Aquestive Therapeutics AQST	395	$ 4.04	-1.28 %	$ 432 M	USA
Viela Bio, Inc. VIE	997	-	-	$ 2.91 B	USA
Coherus BioSciences CHRS	507	$ 1.63	-2.69 %	$ 191 M	USA
Ardelyx ARDX	163	$ 5.8	-2.93 %	$ 1.4 B	USA